SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors react to a massive $27 billion AI infrastructure deal with Meta, which significantly bolsters the company's long-term contracted backlog. While the community is debating the impact of a new $3.75 billion convertible debt offering intended to fund this rapid expansion, many remain bullish on the stock's long-term potential due to sustained backing from industry giants like NVIDIA and Microsoft.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is experiencing heightened volatility and trading volume as investors position themselves ahead of the upcoming fourth-quarter earnings release and monitor key regulatory milestones. The community is actively debating the company's long-term potential as a provider of nuclear energy for AI data centers versus concerns regarding its pre-revenue status, recent insider selling, and the broader macro-driven rotation out of high-beta speculative equities.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is drawing significant attention following its Nasdaq IPO and volatile market debut, with investors debating the growth potential of its drone autonomy software currently deployed in combat zones.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's stock is experiencing heightened volatility and investor attention following positive Phase 3 clinical data for its Retevmo therapy and reports that the company has built significant inventory ahead of a potential April FDA decision on its oral obesity pill. Meanwhile, the broader community remains focused on the intense competitive landscape between LLY and Novo Nordisk, closely monitoring pricing strategies, new drug delivery formats, and ongoing regulatory scrutiny regarding the compounded weight-loss drug market.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to a significant insider purchase of 550,458 shares and a completed capital raise, which the community views as a major vote of confidence in the company's clinical trajectory. Sentiment is currently divided between long-term holders focusing on upcoming Phase 3 milestones and BLA filings, and skeptics who remain concerned about the impact of dilution on shareholder value.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing active community discussion as traders monitor potential buyout interest and growth prospects for its MS therapy, BRIUMVI, ahead of the company's upcoming earnings call. Investors are focused on the firm's revenue trajectory, recent long-term clinical data, and the potential impact of share repurchases on stock performance.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a surge in investor interest and heavy trading volume ahead of the upcoming Optical Fiber Communications Conference (OFC), as market participants speculate on potential major partnership announcements and purchase orders. Community sentiment remains polarized between long-term investors tracking institutional accumulation and technical alignment with hyperscale AI hardware, and skeptics voicing concerns over persistent pre-revenue status and reliance on strategic collaborations.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to a preliminary update from its Phase 3 FLAMINGO-01 trial, which revealed an exceptionally low recurrence rate of less than 1% per year in the open-label arm. Investors are heavily discussing the significance of these consistent long-term results, with the community actively speculating on upcoming abstract titles for the AACR annual meeting and potential strategic partnerships or buyouts.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital Inc. is trending as investors monitor the appointment of a new CFO and anticipate the potential announcement of a major hyperscaler tenant. While some community members remain skeptical of management's communication and deal timelines, others are optimistic that the company's behind-the-meter energy model will drive significant long-term growth as infrastructure demand for AI continues to rise.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to a significant settlement regarding patent litigation, a move that removes a long-standing legal overhang and shifts market focus toward the company's robust oncology pipeline and combination vaccine potential. Community discussion is heavily focused on the stock's high short interest and the potential for a major strategic partnership or buyout to accelerate future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Invesco RAFI US 1000 ETF (PRF) a Strong ETF Right Now?

Should Invesco RAFI US 1000 ETF (PRF) Be on Your Investing Radar?

Shares of shipping and logistic services company Zim Integrated Shipping Services ($ZIM) were trading up nearly 1% (3:49 pm ET) on Tuesday ahead of the company’s third-quarter earnings, with retail sentiment staying bullish.Wall street analysts expect the company to post Earnings Per Share (EPS) of $6.95 on revenue of $2.39 billion. The company missed estimates twice in the last four quarters.Zim will report Q3 earnings after hours on November 20. In the last quarter, it posted $3.08 in EPS, beating Wall Street estimates by over 60%. Its revenues came in at $1.93 billion, 8.6% above estimates.Retail sentiment on the stock has risen to ‘bullish’ (69/100) compared to ‘neutral’ (51/100) a month ago. The accompanying message volumes have climbed into the ‘high’ zone from ‘low’ in the same period.<figure class="image"><img style="aspect-ratio:1304/290;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_20_at_2_32_59_AM_e76b6e947a.png" alt="Screenshot 2024-11-20 at 2.32.59 AM.png" width="1304" height="290"><figcaption>Zim sentiment meter and message volumes on Nov 19 as of 4:03 pm ET| Source: Stocktwits</figcaption></figure>In October, Jefferies downgraded the stock to ‘Hold’ from ‘Buy,’ while retaining its price target at $25. While Barclays analyst Marco Limite raised the company’s price target to $13.90 from $12.30 but kept an ‘Underweight’ rating on the shares. The Fly.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=ZIM">reported.</a>Some Stockwits users suggested the company was undervalued and were optimistic about its earnings prospects.<stembedurl>https://stocktwits.com/Zukio/message/593232178</stembedurl>&nbsp;<stembedurl>https://stocktwits.com/ajetjock/message/593017751</stembedurl> ZIM stock is up 139% on a year-to-date basis.For updates and corrections email newsroom@stocktwits.com.

Zim Integrated Stock Up Ahead of Earnings, Retail’s Bullish

Wall street analysts expect the company to post Earnings Per Share (EPS) of $6.95 on revenue of $2.39 billion. 

Equity

Wall street analysts expect the company to post Earnings Per Share (EPS) of $6.95 on revenue of $2.39 billion. 


Zim Integrated Shipping Services (ZIM) is riding a wave of optimism, both on Wall Street and among retail investors, after exceeding expectations in its Q2 financial report, sending its stock price over 18% in pre-market trading on Monday.Israel-based Zim comfortably beat analyst estimates on both earnings per share (EPS) and sales while it raised its full-year profit outlook.Retail investors on Stocktwits turned increasingly optimistic about Zim, with sentiment shifting deeper into the "bullish" (70/100), and message volume spiking significantly. &nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/ZIM"><img style="aspect-ratio:1320/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ZIM_sentiment_and_message_volume_Aug_19_premarket_14f8a0a41a.png" alt="ZIM sentiment and message volume Aug 19 premarket.png" width="1320" height="318"></a><figcaption>ZIM sentiment and message volume Aug 19 premarket</figcaption></figure>Some users even predict a potential rebound to the $30-mark and beyond in the future.<stembedurl>https://stocktwits.com/TradingTherapy/message/583347764</stembedurl>Contributing to the bullishness is Zim's revised guidance for adjusted earnings before interest, tax, depreciation, and amortization (EBITDA), now expected to be in the range of $2.6 billion to $3 billion, compared with a prior estimate of $1.15 billion to $1.55 billion.Additionally, the company announced a cash dividend of $0.93 per share, reflecting approximately 30% of its Q2 EPS. &nbsp;CEO Eli Glickman attributed the company's success partly to its strategic increase in spot market exposure in the Transpacific trade. This allowed them to capitalize on elevated freight rates. &nbsp;He also anticipates stronger performance in the second half of 2024 due to continued supply disruptions caused by the Red Sea crisis, coupled with favorable demand trends.Missile and drone attacks in the Red Sea have forced many shipping companies to reroute vessels, impacting overall supply chains. &nbsp;Zim's Q2 revenue rose to $1.93 billion from $1.31 billion a year ago, primarily driven by higher freight rates and increased cargo volume.Carried volume rose by 11% year-over-year to 952 thousand twenty-foot equivalent units (TEUs), while the average freight rate per TEU jumped by 40% to $1,674.Year-to-date, ZIM stock has gained an impressive 70%.

Zim's Q2 revenue rose, primarily driven by higher freight rates and increased cargo volume.  Photo via Wikimedia Commons

Zim Integrated Shipping Earnings Top Wall Street Estimates, Upbeat Guidance Lifts Retail Sentiment

Zim Integrated Shipping Services (ZIM) is riding a wave of optimism, both on Wall Street and among retail investors, after exceeding expectations in its Q2 financial report, sending its stock price over 18% in pre-market trading on Monday

Zim Stock Jumps and Retail More Bullish after Q2 Earnings

Retail investors are piling into the stock as the company benefits from ongoing supply chain disruptions.


PRF
Invesco RAFI US 1000 ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PRF News

PRFInvesco RAFI US 1000 ETF